BelHealth Investment Partners has promoted Scott Lee and Inder Tallur to managing partners. Both were most recently senior managing directors at BelHealth.
FORT LAUDERDALE, Fla., March 29, 2021 /PRNewswire/ — BelHealth Investment Partners, LLC (“BelHealth”) has promoted Scott Lee and Inder Tallur to Managing Partner. Both were most recently Senior Managing Directors at BelHealth where they oversaw the day-to-day operations of the firm’s investments and activity over the last decade.
BelHealth is a healthcare focused private equity fund that invests exclusively in majority control positions in U.S. based lower middle market healthcare companies. The senior team of BelHealth, which consists of Founder & Managing Partner Harold S. Blue, Inder Tallur, Scott Lee, and Chief Financial Officer Joseph Wynne, first started working together two decades ago.
Harold Blue, Managing Partner of BelHealth said, “Our team is thrilled to welcome Scott and Inder to lead our partnership and to help solidify and expand our future together.”
Harold Blue, Managing Partner of BelHealth said, “Our team is thrilled to welcome Scott and Inder to lead our partnership and to help solidify and expand our future together. Their reputations with our portfolio company management teams, sector knowledge and years of experience made it a clear decision. Their personalities are complementary to one another and a perfect fit for the firm at this point in our development. As our partner Dennis Drislane transitions into retirement, I am confident that Inder, Scott, and Joe are fully capable and prepared, and BelHealth is in good hands for decades to come.”
About BelHealth Investment Partners
BelHealth Investment Partners is a healthcare private equity firm focused on lower middle market companies. BelHealth has a unique combination of investing, executive management and entrepreneurial experience. BelHealth acquires majority positions in entrepreneur-owned companies that it believes would benefit from its extensive operating and private equity investment expertise. The firm typically invests $20-$50 million per platform company across three core healthcare segments: Services, Products and Distribution. BelHealth is currently investing from Fund II, a $350 million fund.
For further information, please visit:
BelHealth Investment Partners: www.belhealth.com